Pharmaceuticals
Company Overview of APT Pharmaceuticals, Inc.
Company Overview
APT Pharmaceuticals, Inc. engages in the development of cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. Its cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.
700 Airport Boulevard
Suite 350
Burlingame, CA 94010
United States
Founded in 1999
Key Executives for APT Pharmaceuticals, Inc.
Similar Private Companies By Industry
| Company Name | Region |
| Lasko | United States |
| Targent, Inc. | United States |
| Global Biotechnologies, Inc. | United States |
| Greenstone LLC | United States |
| Advanced Clinical Research Services, LLC | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Wilmington, DE | Confidential Medical AdvisorPosted: May 21
- Cambridge, MA | RandstadPosted: May 21
Sponsored Financial Commentaries
Sponsored Links
To contact APT Pharmaceuticals, Inc., please visit www.aptbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
